Toceranib Phosphate
Especificaciones
874819-74-6Número CAS
639-691-4Número CE
5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;phosphoric acidNombre IUPAC
C22H28FN4O6PFórmula química
494.5 g/molPeso molecular
Toceranib phosphate; 874819-74-6; PHA-291639E; SU11654; 24F9PF7J3R; SU-11654; RefChem:57437; Toceranib (phosphate); Toceranib phosphate [USAN]; MFCD25372034; 5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;phosphoric acid; SU 11654; Toceranib phosphate (USAN); PHA291639; C22H28FN4O6P; UNII-24F9PF7J3R; (Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-n-(2-(pyrrolidin-1-yl)ethyl)-1h-pyrrole-3-carboxamide phosphate; PHA 291639E; 5-?[(Z)?-?(5-?Fluoro-?1,?2-?dihydro-?2-?oxo-?3H-?indol-?3-?ylidene)?methyl]?-?2,?4-?dimethyl-?N-?[2-?(1-?pyrrolidinyl)?ethyl]?-1H-?pyrrole-?3-?carboxamide Phosphate; orb1299858; CHEMBL2103833; SCHEMBL29397832; TOCERANIB PHOSPHATE [MI]; Toceranib phosphate(SU 11654); AOORBROPMMRREB-HBPAQXCTSA-N; Toceranib phosphate(SU 11654)?; HY-10330A; s5272; AKOS027427177; AKOS037645104; CCG-269649; CS-1231; Toceranib phosphate - Bio-X trade mark; TOCERANIB PHOSPHATE [GREEN BOOK]; AS-57142; BT162330; FT104292; T7394; D08544; F866643; Q27253845; (Z)-5-((5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-N-(2-PYRROLIDIN-1-YLETHYL)-1H-PYRROLE-3-CARBOXAMIDE PHOSPHATE; 1H-PYRROLE-3-CARBOXAMIDE, 5-((Z)-(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-N-(2-(1-PYRROLIDINYL)ETHYL)-, PHOSPHATE (1:1); 5-[(Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide phosphate (1:1); 5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;phosphoric acidSinónimos